Dr Reddys Laboratories RDY
NYSE RDY
$13.22 +0.02 (+0.15%)
At close: Oct 22, 2026 · 4:00 PM EDT

Dr Reddys Laboratories (RDY) Curent Deferred Tax Liability (2010 - 2014)

Updated

Analysis

Dr Reddys Laboratories (RDY) Curent Deferred Tax Liability (2010 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Dr Reddys Laboratories 11.03 Bn 10.44 Bn 396.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 55.31 Mn
Mar 31, 2013 33.35 Mn
Mar 31, 2010 -32.10
API Access

Dr Reddys Laboratories Curent Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=RDY&period=max&api_key=YOUR_API_KEY